{"id":1010480,"date":"2026-10-15T07:18:42","date_gmt":"2026-10-15T11:18:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/"},"modified":"2026-10-15T07:18:42","modified_gmt":"2026-10-15T11:18:42","slug":"ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/","title":{"rendered":"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">JUPITER, Fla., Oct.  15, 2026  (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026. The company will hold a conference call beginning at 8:30 a.m. Eastern time to discuss the results and provide a general business update.<\/p>\n<table style=\"border-collapse: collapse;width:99%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"max-width:25%;min-width:25%\">\n            <strong>Conference Call and Webcast Information<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:22%;width:22%;min-width:22%\">\u00a0<\/td>\n<td style=\"max-width:78%;width:78%;min-width:78%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:25%;min-width:25%\">Date:<\/td>\n<td style=\"max-width:75%;min-width:75%\">Thursday, October 29, 2026<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>8:30 a.m. Eastern time<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>Conference Call:<\/td>\n<td>United States (Local):\u00a0+1 (585) 542-9983<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>United States (Toll-Free):\u00a0+1 (833) 461-5787<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>International: <a href=\"https:\/\/help.events.q4inc.com\/eahc\/international-dial-in-numbers\" rel=\"nofollow\" target=\"_blank\">Global Dial-in Numbers<\/a><\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>Meeting ID: 708822080<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>Live and replay webcasts of the call are available <a href=\"https:\/\/investor.ligand.com\/news-and-events\/events-and-presentations\/default.aspx\" rel=\"nofollow\" target=\"_blank\"><strong>here<\/strong><\/a>.<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong><br \/>\n          <br \/>About Ligand<\/strong><br \/>\n        <br \/>Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. Ligand owns and manages one of the largest and most diversified portfolios of biopharmaceutical royalties in the industry, with economic interests in more than 200 development and commercial-stage assets. Ligand funds high-value programs in exchange for long-term economic interests, aligning capital with clinical and commercial success. Ligand\u2019s royalty portfolio is designed to deliver consistent and predictable revenue streams across a broad range of therapeutic assets. Ligand also licenses its proprietary technologies, Captisol\u00ae and NITRICIL\u2122, to support drug development and formulation across its global partner network. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8abHG6deRApOk-8jnlOGeN68I1Mlz1GePAyqTprpG0Q8mEaYhFYBjujIXfHdRPtIjW6539fplCHDP-uJ80lR-g==\" rel=\"nofollow\" target=\"_blank\"><u>www.ligand.com<\/u><\/a> or follow Ligand on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ou1T3n7eZKg1e9pVdmnJ50fMYCXUwB0F3Yu9oB7QyYXj6P_IBD0UkX5rgdPo0lNve-29-cxvzf5r4jE9T7Nk2Q==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IyktccKQHbuo-8CjIjOtsoIHpwPZwmXzDUZ4tmGmmOJ8-diGeiUGLHLzVxKJzsZaHTLnATzdD_u8OY-IwryIUVjWBZE_FdnRIUdyyHJpfWqPJEs_stBHuk5PoEUMRU8e\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Investors:<br \/>Melanie Herman<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RnsqO-rbunN7bLzxZe8xO3lDk1McoTPxJMpErnMQPVZRkP5SCRY0ViMu9Vg2alKnzPQgUInRNCWraOS_8rONq0br30G7DUwQs6PqEM2DEX0=\" rel=\"nofollow\" target=\"_blank\"><u>investors@ligand.com<\/u><\/a><br \/>(858) 550-7761<\/p>\n<p>Media: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Kellie Walsh<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=T9zPRWELNz5l_N76egesfauyh5ssYmo3T97LoriHrftal_RQOpXame0tpkdrfUavTTbDF0dZOdqgkFuhjsFxbGt7bYWLTxGmfoTRnPi1y_E=\" rel=\"nofollow\" target=\"_blank\"><u>media@ligand.com<\/u><\/a><br \/>(914) 315-6072<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmEwMzAxYzAtYWJjMS00MmJkLWEwMTktNDA2OTQxMWE3NWI5LTEwMTgxMzctMjAyNi0xMC0xNS1lbg==\/tiny\/Ligand-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>JUPITER, Fla., Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026. The company will hold a conference call beginning at 8:30 a.m. Eastern time to discuss the results and provide a general business update. Conference Call and Webcast Information \u00a0 \u00a0 Date: Thursday, October 29, 2026 \u00a0 \u00a0 Time: 8:30 a.m. Eastern time \u00a0 \u00a0 Conference Call: United States (Local):\u00a0+1 (585) 542-9983 \u00a0 United States (Toll-Free):\u00a0+1 (833) 461-5787 \u00a0 International: Global Dial-in Numbers \u00a0 Meeting ID: 708822080 \u00a0 \u00a0 Webcast: Live and replay webcasts of the call are available here. About Ligand Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1010480","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JUPITER, Fla., Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026. The company will hold a conference call beginning at 8:30 a.m. Eastern time to discuss the results and provide a general business update. Conference Call and Webcast Information \u00a0 \u00a0 Date: Thursday, October 29, 2026 \u00a0 \u00a0 Time: 8:30 a.m. Eastern time \u00a0 \u00a0 Conference Call: United States (Local):\u00a0+1 (585) 542-9983 \u00a0 United States (Toll-Free):\u00a0+1 (833) 461-5787 \u00a0 International: Global Dial-in Numbers \u00a0 Meeting ID: 708822080 \u00a0 \u00a0 Webcast: Live and replay webcasts of the call are available here. About Ligand Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies &hellip; Continue reading &quot;Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T11:18:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026\",\"datePublished\":\"2026-10-15T11:18:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/\"},\"wordCount\":230,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/\",\"name\":\"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=\",\"datePublished\":\"2026-10-15T11:18:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/","og_locale":"en_US","og_type":"article","og_title":"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - Market Newsdesk","og_description":"JUPITER, Fla., Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026. The company will hold a conference call beginning at 8:30 a.m. Eastern time to discuss the results and provide a general business update. Conference Call and Webcast Information \u00a0 \u00a0 Date: Thursday, October 29, 2026 \u00a0 \u00a0 Time: 8:30 a.m. Eastern time \u00a0 \u00a0 Conference Call: United States (Local):\u00a0+1 (585) 542-9983 \u00a0 United States (Toll-Free):\u00a0+1 (833) 461-5787 \u00a0 International: Global Dial-in Numbers \u00a0 Meeting ID: 708822080 \u00a0 \u00a0 Webcast: Live and replay webcasts of the call are available here. About Ligand Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies &hellip; Continue reading \"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-15T11:18:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026","datePublished":"2026-10-15T11:18:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/"},"wordCount":230,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/","name":"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=","datePublished":"2026-10-15T11:18:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwMCM3ODkyMDI2IzIwMDY1NjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-report-third-quarter-2026-financial-results-on-october-29-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1010480"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010480\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1010480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1010480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1010480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}